Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15510,43,0.45 [0.30-0.66],5.856206949844042e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18092,53,2.10 [1.53-2.89],4.914763059272755e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15938,46,5.65 [3.27-9.75],5.281880540728136e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18475,53,3.51 [2.13-5.79],9.16921451823612e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18450,53,4.37 [2.25-8.51],1.4167019024452076e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18268,55,3.11 [1.79-5.39],5.455926813413603e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16011,46,6.95 [3.08-15.67],2.949922797600232e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,15938,46,2.52 [1.72-3.70],2.4193995748296544e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18504,53,6.00 [2.82-12.77],3.2575153629090927e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16015,46,1.98 [1.48-2.64],3.459993905584653e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18475,53,8.96 [4.72-17.02],2.097799457589853e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,17999,53,3.55 [2.20-5.74],2.2199079817180602e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15639,44,4.24 [2.05-8.76],9.660590866899352e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18475,53,5.31 [2.72-10.35],9.625519096784768e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18353,54,9.42 [3.09-28.67],7.862925708661883e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18417,55,3.34 [2.09-5.34],5.057591126867846e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18391,53,2.23 [1.55-3.22],1.7503641779717184e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18475,53,3.22 [1.91-5.42],1.043347115374542e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18609,55,4.15 [2.53-6.80],1.6236622806418432e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18079,52,4.20 [2.76-6.38],1.876258054012616e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18637,55,2.77 [1.86-4.12],4.971961098126956e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18504,53,2.63 [1.64-4.22],5.567632297885373e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18268,55,3.48 [2.28-5.30],7.444270664197064e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18385,53,3.48 [1.86-6.50],8.957945456809164e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,17999,53,2.75 [1.98-3.82],1.8108553746787998e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15639,44,4.91 [2.43-9.93],9.27085050772581e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18581,55,3.76 [2.15-6.56],3.2198564925873445e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18537,55,3.82 [2.48-5.87],1.0831686665373642e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18337,53,3.49 [1.86-6.52],9.399050824213798e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17795,50,3.96 [2.32-6.76],4.871596752103086e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17777,52,5.06 [2.70-9.49],4.327687778620397e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18409,53,3.39 [2.16-5.31],1.040657566848584e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15639,44,4.98 [3.00-8.28],5.93812920029733e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18581,55,6.60 [4.04-10.79],4.8731041176043645e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18637,55,2.92 [1.98-4.31],6.373854771602867e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,15990,45,6.58 [3.94-11.00],6.57099853568596e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18409,53,5.36 [3.03-9.46],7.403693804562534e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17745,50,5.44 [2.97-9.97],4.1560446949598e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18581,55,3.43 [1.99-5.90],8.479135285407422e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18415,53,2.38 [1.85-3.07],1.6975732135316432e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15962,46,2.56 [1.74-3.75],1.5981887136016425e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18546,55,3.52 [2.20-5.64],1.607532419237409e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18415,53,4.05 [2.23-7.35],4.255788990979406e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18092,53,5.16 [3.04-8.78],1.345602814725606e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,17999,53,2.46 [1.69-3.58],2.859238742983735e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18591,55,7.09 [3.24-15.51],9.237046867020856e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18646,55,4.46 [2.89-6.87],1.4088785112451047e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18385,53,4.35 [2.09-9.03],8.220818782089928e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18268,55,2.48 [1.62-3.81],3.13030843421732e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18108,52,2.68 [1.94-3.70],2.6511790831213863e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18469,53,6.33 [3.59-11.16],1.6864151845664168e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18166,54,2.66 [1.75-4.03],4.200047724683717e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18417,55,5.09 [2.35-11.06],3.873085785518563e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18521,54,0.23 [0.12-0.42],1.574986295052739e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18446,53,4.51 [2.29-8.88],1.286537069457245e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18475,53,2.03 [1.62-2.53],3.73148765919967e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18581,55,1.60 [1.31-1.95],3.634654744890748e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18475,53,2.30 [1.85-2.86],5.4869455283725324e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18458,53,7.29 [3.95-13.45],2.0250914133938812e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18540,55,1.75 [1.33-2.32],7.663239178694447e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18185,52,4.95 [2.99-8.19],4.777146692732432e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15896,46,2.29 [1.53-3.43],5.226240432702602e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18326,53,4.83 [2.65-8.81],2.827279241387913e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18568,55,6.25 [3.23-12.10],5.2823047268624576e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18591,55,4.60 [3.11-6.80],1.832020056185026e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18409,53,0.52 [0.39-0.70],1.0439308087113151e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,15938,46,2.54 [1.59-4.05],9.566542779119032e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18474,53,5.22 [2.91-9.35],2.7886644523392275e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,15968,45,2.56 [1.69-3.87],8.257074788975366e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18384,53,4.72 [2.63-8.45],1.853462267367725e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18234,55,4.48 [2.67-7.52],1.4361227859752593e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17771,50,4.83 [2.89-8.09],2.103956625530658e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18646,55,7.95 [4.25-14.85],7.965442966498335e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18240,55,3.73 [1.96-7.10],6.348792140279754e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18409,53,1.59 [1.30-1.96],1.0267340847625223e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",15990,45,2.03 [1.43-2.89],8.340200705599882e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18646,55,2.21 [1.52-3.21],3.26992887065354e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16000,46,4.35 [2.08-9.08],9.22646573556942e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18553,55,0.31 [0.19-0.52],5.252787966739752e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18415,53,0.28 [0.18-0.42],8.74348041839988e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18458,53,5.24 [2.32-11.83],6.81521494076563e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18376,53,3.86 [2.06-7.24],2.558396126125084e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18581,55,7.49 [3.98-14.12],4.679612760744221e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15546,45,2.46 [1.81-3.36],1.0502233188039409e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18355,53,5.70 [3.47-9.35],5.808634754429401e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,15934,46,2.26 [1.70-2.99],1.3648506404304529e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18326,53,5.65 [3.29-9.72],3.85738316819465e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18646,55,2.32 [1.65-3.26],1.1577538212614152e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18568,55,8.27 [4.68-14.61],3.3684352688774053e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,15962,46,4.85 [2.88-8.19],3.2916915285932832e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15613,45,2.26 [1.56-3.27],1.652239532773712e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18415,53,2.21 [1.51-3.24],4.585973961760274e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18637,55,3.00 [1.79-5.05],3.217589776384694e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18092,53,1.55 [1.32-1.82],6.473936131586886e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18415,53,4.68 [3.02-7.26],5.005844152796778e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18409,53,4.79 [2.70-8.48],7.799007965255624e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18184,55,2.48 [1.65-3.71],1.1550322306009031e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18591,55,3.21 [2.08-4.96],1.520880433307116e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18304,53,5.28 [3.05-9.14],2.895301102780141e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18359,53,6.55 [3.67-11.69],2.0820006299375758e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15576,46,4.41 [2.80-6.95],1.6498975330931674e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18108,52,1.61 [1.35-1.92],1.0437605769871033e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18475,53,4.89 [2.65-9.03],3.739634154249329e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18192,53,3.19 [2.31-4.41],2.353548743374368e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18356,53,3.52 [2.10-5.91],1.9572251663615434e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18108,52,1.65 [1.38-1.98],6.337163370860165e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18475,53,3.04 [1.89-4.88],4.592722571035381e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18326,53,2.25 [1.75-2.90],3.3695549017429033e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18637,55,3.39 [2.29-5.02],9.867467859255839e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18108,52,3.99 [2.45-6.51],2.8415572800585906e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18409,53,3.09 [1.78-5.34],5.7364682796024746e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18108,52,6.35 [3.64-11.06],6.928639607988863e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18068,52,1.92 [1.43-2.57],1.3352046367043484e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18321,52,2.67 [1.74-4.11],7.790682248978646e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18504,53,8.90 [5.39-14.70],1.269295924056509e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18353,52,1.83 [1.37-2.46],4.664857443638497e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,15934,46,1.87 [1.38-2.51],4.135684320960869e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18299,53,4.03 [2.68-6.07],2.223608103840046e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18409,53,0.34 [0.22-0.54],4.239449568149304e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18326,53,1.64 [1.35-1.98],4.0405343179756937e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,15934,46,2.22 [1.61-3.08],1.430931414019807e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18581,55,4.50 [2.35-8.62],5.825722814163437e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18405,53,2.19 [1.51-3.17],3.4867273374775945e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18637,55,3.17 [1.85-5.43],2.6016076488588368e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18637,55,2.83 [1.76-4.54],1.598814488411982e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,15962,46,2.38 [1.64-3.44],4.620871607051185e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18385,53,2.95 [2.06-4.23],3.246861813329374e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18604,55,2.94 [1.95-4.43],2.788431694619899e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18240,55,3.30 [2.01-5.41],2.198429667138882e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18417,55,3.57 [2.20-5.80],2.832277130550883e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18396,53,7.48 [4.43-12.64],5.5815718426168936e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18397,55,3.44 [1.85-6.40],9.983585643204282e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18556,55,4.56 [2.32-8.98],1.1451472530288994e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18108,52,3.36 [2.11-5.34],3.039958818359693e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,15962,46,3.86 [2.19-6.80],2.7940415970433777e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,15968,45,2.62 [1.75-3.92],3.211102353599092e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16015,46,9.11 [4.08-20.36],7.271725609488208e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18417,55,3.55 [2.08-6.08],3.68931611089112e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18646,55,3.30 [1.90-5.72],2.2314922058641e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,17999,53,1.80 [1.39-2.33],9.34226334961032e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18292,52,6.84 [4.02-11.64],1.4201741133036285e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18298,52,2.46 [1.61-3.78],3.5978863794136953e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18458,53,5.31 [2.57-10.95],6.237723285108029e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18459,53,2.18 [1.52-3.12],2.00019802719348e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,15990,45,1.81 [1.43-2.30],1.1097172653201416e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18458,53,6.16 [3.00-12.64],7.238591526665083e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18384,53,4.05 [2.36-6.97],4.3077031791417526e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,15938,46,4.52 [2.73-7.50],4.743109633194385e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18591,55,4.61 [2.21-9.60],4.560198629402192e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18397,55,5.06 [3.05-8.41],3.6297053263588937e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18458,53,3.36 [2.02-5.59],3.031453290591743e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,17971,54,2.20 [1.57-3.08],4.754935470315344e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18417,55,3.23 [2.05-5.11],4.671320178228932e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,15962,46,3.22 [2.22-4.67],6.900697567448182e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18417,55,1.41 [1.19-1.67],5.709615601645589e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,15968,45,2.38 [1.56-3.61],4.903553212771043e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18415,53,3.33 [2.14-5.19],9.835390197670601e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18326,53,1.89 [1.42-2.50],9.996577422300274e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18537,53,9.95 [3.80-26.05],2.856526425485118e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15841,46,3.57 [2.20-5.79],2.7572087174501785e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,15962,46,2.75 [1.78-4.25],5.376310943784146e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18559,55,5.11 [3.54-7.39],3.9589629109495706e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18326,53,3.72 [1.99-6.97],3.879734377117069e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18637,55,5.52 [3.13-9.73],3.392385383314032e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18268,55,5.04 [2.52-10.11],5.078566714091355e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18176,52,1.90 [1.39-2.62],7.11902895718068e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18415,53,4.36 [2.49-7.65],2.846990856714822e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18415,53,5.28 [3.29-8.46],4.971099372924556e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18417,55,3.26 [2.05-5.19],5.849564549702186e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18272,53,4.26 [2.18-8.32],2.2705423857417423e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,15962,46,3.10 [2.02-4.77],2.64164419340466e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18504,53,1.85 [1.37-2.49],5.067237627378488e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15715,46,2.71 [1.66-4.42],6.265440989329894e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18308,53,3.96 [2.45-6.40],2.003399204832163e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18537,53,2.04 [1.49-2.80],1.0355716802134018e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,15968,45,2.59 [1.85-3.62],2.316275086039308e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18328,52,2.19 [1.55-3.11],1.0110289035762089e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18646,55,1.94 [1.43-2.64],2.4898503262077026e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18646,55,2.09 [1.61-2.73],4.206467505109951e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18415,53,4.40 [2.41-8.02],1.3837351519689546e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18560,54,4.26 [2.12-8.55],4.5323572814999616e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15546,45,4.34 [2.23-8.44],1.5220454376283376e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,17999,53,1.91 [1.48-2.48],9.07660516108124e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18591,55,3.68 [1.93-7.04],8.008988999822537e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,17917,54,4.89 [3.16-7.56],9.289886481153866e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18581,55,4.95 [2.60-9.41],1.061152654610193e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,15990,45,2.77 [1.67-4.60],7.759169760140509e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18417,55,0.23 [0.16-0.35],3.33640852915523e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18417,55,8.19 [3.76-17.84],1.228037723272632e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,15930,46,2.86 [1.70-4.82],7.49569663660923e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16000,46,4.79 [2.85-8.03],2.93761551437519e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18475,53,2.79 [1.79-4.37],6.845308956704542e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18409,53,4.61 [2.66-8.00],5.193825648280983e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18415,53,2.13 [1.56-2.92],2.023785224789999e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18350,52,2.60 [1.66-4.07],3.194656781890189e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18240,55,0.49 [0.35-0.70],8.001192886530285e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,17999,53,4.06 [2.84-5.80],1.5751923648192582e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,17999,53,3.76 [2.10-6.73],7.973817314338599e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18415,53,2.95 [1.93-4.49],4.85956962980615e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15639,44,0.16 [0.07-0.39],5.323305351120122e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18334,53,4.35 [2.46-7.71],4.391517197251898e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18458,53,7.97 [3.10-20.45],1.5914662364310617e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15583,44,0.30 [0.18-0.50],3.362725074572621e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18421,52,2.40 [1.71-3.35],3.284201813535501e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18458,53,4.63 [3.01-7.12],3.014939203091984e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16011,46,5.47 [2.48-12.05],2.5615684287829987e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18417,55,3.72 [2.19-6.34],1.323256691155043e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18092,53,5.33 [3.08-9.20],1.9836347506143164e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18581,55,7.86 [4.26-14.52],4.4815130598746395e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15715,46,2.01 [1.43-2.83],6.233790343096441e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18504,53,2.82 [1.72-4.62],4.009989816041507e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18247,52,4.22 [2.27-7.85],5.239601952488972e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18067,53,2.15 [1.64-2.82],2.6786920536465493e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18637,55,3.38 [2.17-5.25],6.270484304726345e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18458,53,3.43 [2.03-5.81],4.394296398394858e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18415,53,3.50 [1.91-6.43],5.291650567582707e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18591,55,3.44 [2.08-5.70],1.560842295495324e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18415,53,6.36 [3.91-10.34],9.316039736447553e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18415,53,2.38 [1.88-3.01],4.911284481954327e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18581,55,4.73 [2.40-9.33],7.369780229693412e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18604,55,5.63 [3.68-8.63],1.9410426077848687e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18268,55,2.01 [1.48-2.72],7.315835915955478e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18581,55,4.04 [2.95-5.54],2.9663881281249693e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18268,55,3.26 [2.25-4.71],3.2732360151424047e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18268,55,3.13 [1.94-5.06],3.05243813961919e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18482,53,7.61 [3.92-14.74],1.877161986602245e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18581,55,3.84 [1.98-7.44],6.656641418800025e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18393,53,4.38 [2.96-6.47],1.389976553985544e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18415,53,3.14 [1.78-5.54],7.44935409209179e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17485,51,3.66 [2.52-5.33],1.0401326913894496e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,15962,46,4.93 [3.02-8.04],1.6835683323826235e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18092,53,1.99 [1.46-2.71],1.539262214635227e-05
